Data Sharing Through Dashboards: The Who, What, Where, When, and Why

Presented April 26, 2019.

Description: Join us for this lightning talk webinar experience where you will see multiple examples of data dashboards and learn more about who they were created for, how they were developed, where and when the data is being shared, and what impact the dashboard has had on improving public health practice. We will hear from 5 presenters from around the public health community as they discuss their work on opioid, flu, and general disease surveillance dashboards.

Presenters addressed the following questions:

April 30, 2019

Turning the Tide on the Opioid Epidemic

Presenters

Susan Robinson, Vaccine-Preventable Disease Epidemiologist, Arizona Department of Health Services

Erica Weis, Injury Prevention Epidemiologist, Arizona Department of Health Services

Background

March 27, 2019

Enhanced State Opioid Overdose Surveillance (ESOOS) Program Overview

These slides were presented at the Enhanced State Opioid Overdose Surveillance (ESOOS) Program Overview Partner meeting, led by CDC and organized by ASTHO in March of 2019. 

Presenters

Puja Seth, PhD – Lead, Epidemiology and Surveillance

Alana Vivolo-Kantor, PhD – Morbidity Lead

Christine L. Mattson, PhD – Mortality Lead

Objectives

March 27, 2019

Using probabilistic matching to improve opioid drug overdose surveillance, New Jersey

The opioid drug overdose crisis presents serious challenges to state-based public health surveillance programs, not the least of which is uncertainty in the detection of cases in existing data systems. New Jersey historically had slightly higher unintentional drug overdose death rates than the national average, but by 2001 dramatic increases in drug overdose deaths in states like West Virginia began to drive up the national rate (Figure 1).

June 18, 2019

Drug Overdose Trends among Black Indiana Residents: 2013-2017

Black Hoosiers, the largest minority population in Indiana, make up almost 10% of the state's population, and accounted for 8% of the total resident drug overdose deaths from 2013-2017 compared to whites at 91%. However, a closer look at race-specific mortality rates might reveal racial inequalities. Therefore, the purpose of this project was to analyze drug overdose morality rates among white and black Hoosiers to discover possible racial inequalities and to discover trends in drug involvement in overdose deaths among blacks.

June 18, 2019

Evaluation of Syndromic Surveillance for Opioid Overdose Reporting in Illinois

Accuracy in identifying drug-related emergency department admissions is critical to understanding local burden of disease and assessing effectiveness of drug abuse prevention and overdose-reduction initiatives. In 2018 the Illinois Department of Public Health (IDPH) began implementation of a mandatory opioid overdose reporting law, applicable to all hospital emergency departments (ED). The mandate requires reporting of patient demographics, causal substance and antagonist ED administration within 48 hours of presentation. This reporting is not name-based.

June 18, 2019

Using the CA Opioid Overdose Surveillance Dashboard to track opioid overdose deaths

California continues to face a serious public health crisis with the opioid epidemic having substantial health and economic impacts. The epidemic is dynamic and rapidly changing, involving both prescription opioids influenced by prescribing and dispensing patterns as well as illicit opioids influenced by the availability of heroin and recently, the increased availability of fentanyl. The complexity of the issue necessitates data-informed actions through multi-sector, strategic collaboration at both the state and local levels to address the problem comprehensively.

June 18, 2019

Identification of Clinical Indicators of Opioid Overdose using innovative EMS software analytics.

In North America we experience the highest rate of drug related mortality in the world. In the US, overdose is now the leading cause of death among adults under 50. Each day more than 115 people in the United States die due to an opioid overdose. The opioid overdose national crisis is rapidly evolving due to changes in drug availability and the presence of adulterated fentanyl in some areas leading to a critical need for innovative methods to identify opioid overdoses for both surveillance and intervention purposes.

June 18, 2019

Rhetorical Framing and Needle Exchange in Rural Indiana: Shifting Perspectives and Policy

Political discourse surrounding matters of public health is exigent because human life is at stake this is unquestionably the case with respect to widespread opioid addiction. While intravenous drug use itself is described as a health concern, the spread of diseases such as hepatitis C and HIV through the sharing of needles is a disease surveillance emergency. This research centers on municipal-level decision making in the community of greater Lafayette, Indiana.

June 18, 2019

Adolescent prescription opioid misuse, illicit opioid use and overdose

The number of overdose deaths involving illicit opioids such as heroin and illicitly-manufactured fentanyl (IMF) is now higher than deaths involving prescription opioids. Adolescents misusing prescription opioids are more likely to use heroin. Although nonmedical use of prescription opioids (NUPO) among adolescents is decreasing, there is still relatively high prevalence of this behavior.

June 18, 2019

Pages

Contact Us

National Syndromic
Surveillance Program

Email:nssp@cdc.gov

The National Syndromic Surveillance Program (NSSP) is a collaboration among states and public health jurisdictions that contribute data to the BioSense Platform, public health practitioners who use local syndromic surveillance systems, Center for Disease Control and Prevention programs, other federal agencies, partner organizations, hospitals, healthcare professionals, and academic institutions.

Site created by Fusani Applications